THCHealthcare · Medical Care FacilitiesThe 22 Wall Street analysts covering Tenet Healthcare Corp. hold a median 12-month price target of $285 — +8.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 97 of 100 as at 19 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Tenet Healthcare Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (95): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Volatility (47): The share price moves around a lot.
Size (10): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on THC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +8.8% from it.
Of the 20 most recent actions, 11 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 3 Aug 2026 | Wells Fargo | Maintains | Overweight | $231 → $281 |
| 28 July 2026 | Baird | Maintains | Neutral | $210 → $280 |
| 28 July 2026 | Guggenheim | Maintains | Buy | $242 → $283 |
| 28 July 2026 | Truist Securities | Maintains | Buy | $270 → $290 |
| 27 July 2026 | Morgan Stanley | Maintains | Overweight | $254 → $274 |
| 27 July 2026 | RBC Capital | Maintains | Outperform | $236 → $283 |
| 27 July 2026 | TD Cowen | Maintains | Buy | $233 → $263 |
| 27 July 2026 | UBS | Maintains | Buy | $288 → $308 |
| 24 July 2026 | Barclays | Maintains | Overweight | $240 → $271 |
| 24 July 2026 | Barclays | Maintains | Overweight | — |
| 20 July 2026 | Guggenheim | Maintains | Buy | — |
| 20 July 2026 | Guggenheim | Maintains | Buy | $252 → $242 |
| 13 July 2026 | Wells Fargo | Maintains | Overweight | — |
| 13 July 2026 | Wells Fargo | Maintains | Overweight | $213 → $231 |
| 9 July 2026 | Barclays | Maintains | Overweight | $238 → $240 |
| 9 July 2026 | Barclays | Maintains | Overweight | — |
| 22 June 2026 | TD Cowen | Maintains | Buy | — |
| 5 May 2026 | Baird | Maintains | Neutral | — |
| 5 May 2026 | Barclays | Maintains | Overweight | — |
| 4 May 2026 | Stephens & Co. | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. THC appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 18 Sept 2026, Tenet Healthcare Corp. returned +37.7% against +16.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 58% of US stocks
Cheaper than 70% of US stocks
Cheaper than 22% of US stocks
Cheaper than 47% of US stocks
Higher than 43% of US stocks
Higher than 90% of US stocks
Higher than 93% of US stocks
Higher than 77% of US stocks
Higher than 70% of US stocks
Higher than 90% of US stocks
Higher than 89% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Tenet Healthcare Corp. has a market value of $21.1B and an enterprise value of $36.2B.
Revenue in the twelve months to 30 June 2026: $22.6B. The latest quarter grew 6.8% year on year.
Net income over the same four quarters: $3.2B, a 14.0% net margin.
Diluted earnings per share, trailing twelve months: $25.93.
Free cash flow in the twelve months to 30 June 2026: $3.0B.
Tenet Healthcare Corp. spent $1.7B on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 10.1×; forward P/E: 12.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.04%, paying out 0% of earnings.
Tenet Healthcare Corp. employs 77,000 people — $294K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Tenet Healthcare Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Tenet Healthcare director Nadja West sold 1,152 shares at $258.80 per share, an amount equal to 5% of her directly held equity stake prior to the filing. The transaction was disclosed in an insider filing.
Why it matters — THC watchers track insider transactions as they may indicate director sentiment about the company's stock.
According to Zacks Investment Research, Tenet Healthcare (THC) is identified as a top-ranked value stock through the firm's Style Scores, which helps investors identify top-rated stocks based on their investing style.
Why it matters — The ranking signals that THC stands out to investors seeking value-oriented stocks, based on Zacks' style-based screening approach.
Zacks Investment Research published an Industry Outlook article highlighting Tenet Healthcare, Acadia Healthcare, and Community Health Systems. The companies were featured in this industry outlook report.
Why it matters — THC watchers would be interested because Tenet is featured in Zacks' industry outlook, offering analyst perspective on the sector the company operates in.
Zacks reported that medical-hospital operators are benefiting from steady care demand while sharpening efficiency and portfolio strategy, and noted that investors may want to track THC, along with ACHC and CYH, as hospital stocks riding strong demand and improved efficiency.
Why it matters — A THC watcher would care because the report highlights hospital operators, including THC, as beneficiaries of steady demand and improved efficiency.
Zacks Investment Research discusses its Zacks Rank system, which emphasizes earnings estimates and estimate revisions to identify strong stocks, while also monitoring value, growth, and momentum trends. The item poses the question of whether Tenet Healthcare is currently undervalued.
Why it matters — THC watchers would be interested because the piece evaluates the stock through Zacks' earnings-estimate and valuation framework, potentially signalling how the company is viewed by stock screeners.
The 22 Wall Street analysts covering Tenet Healthcare Corp. have a median 12-month price target of $285, with estimates ranging from $260 to $315. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 22 analysts covering Tenet Healthcare Corp., 19 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Tenet Healthcare Corp. 97 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 19 Sept 2026, Tenet Healthcare Corp. ranks 97 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (95 of 100).
No one can know that. What the data says: the median 12-month target from 22 analysts implies +8.8% from the last close, and Ticker Nerd's factor model ranks Tenet Healthcare Corp. 97 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Tenet Healthcare Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for THC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $260 to $315 over the next 12 months.
Tenet Healthcare Corp. returned +37.7% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Tenet Healthcare Corp. is a diversified healthcare services company focused on delivering hospital care, outpatient treatment, and related support services across the United States.
The most recent item we track (The Motley Fool, 20 Sept 2026): "Tenet Healthcare Director Nadja West Sells 1,152 Shares". Tenet Healthcare director Nadja West sold 1,152 shares at $258.80 per share, an amount equal to 5% of her directly held equity stake prior to the filing. The transaction was disclosed in an insider filing.
Tenet Healthcare Corp. is a diversified healthcare services company focused on delivering hospital care, outpatient treatment, and related support services across the United States. The company operates acute care and specialty hospitals, ambulatory surgery centers, and a broad network of outpatient facilities that provide services such as emergency care, diagnostics, radiology, respiratory therapy, clinical laboratories, and pharmacies. Its business also includes physician services and revenue cycle management through Conifer Health Solutions, which supports hospitals, health systems, physician practices, and employers with administrative and financial operations. Through this combination of inpatient care, ambulatory surgery, and healthcare services infrastructure, Tenet Healthcare Corp. plays an important role in providing coordinated care delivery across multiple settings and patient needs. The company is headquartered in Dallas, Texas.
CEO Dr. Saumya Sutaria M.D. · 77,000 employees · United States · https://www.tenethealth.com
